№ files_lp_3_process_7_083041
File format: docx
Character count: 9768
File size: 86 KB
The document outlines a public consultation on revised guidelines related to the expiry of compounded parenteral medicines, focusing on the application of the Pharmacy Board of Australia’s standards and the potential impact on patient safety and access to compounded medicines.
Organisation name:
Australian Custom Pharmaceuticals Pty Ltd
Contact name:
Daryll Knowles
E-mail address:
[content redacted]
Date:
1 February 2016
Region:
Australia
Topic:
Pharmacy Guidelines
Document type:
Consultation Paper
Institution:
Pharmacy Board of Australia
Target audience:
Pharmacists, Compounding Professionals
Period of validity:
Indefinite
Approval date:
Not specified
Amendment date:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Year:
2020
Region / city:
Australia
Topic:
Pharmaceutical manufacturing, Good Manufacturing Practice (GMP)
Document type:
Guide
Organization / institution:
Therapeutic Goods Administration (TGA)
Author:
Commonwealth of Australia
Target audience:
Licensed pharmaceutical manufacturers, regulatory bodies
Effective period:
Indefinite
Approval date:
September 2020
Amendment date:
N/A
Date:
November 17, 2025
Type of document:
Cover letter
Manuscript title:
Effectiveness, Adherence, and Safety of Branded Wegovy™ vs. Compounded Semaglutide + Cyanocobalamin (CSC)
Article type:
Original Article
Journal:
The Journal of Obesity and Metabolism
Author:
Shanmugesh Raja, MS
Affiliation:
University of California, San Francisco
Study design:
Retrospective cohort study
Data source:
De-identified telemedicine cohort
Interventions studied:
FDA-approved semaglutide (Wegovy™) and compounded semaglutide + cyanocobalamin
Outcomes assessed:
Weight-loss magnitude and milestones, treatment adherence and persistence, adverse event reporting
Regulatory context:
FDA-approved semaglutide compared with compounded formulation
Conflict of interest disclosure:
Confirmed disclosed
Prior publication status:
Not previously published and not under consideration elsewhere
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Year:
2023
Region / city:
Canberra
Topic:
Parenteral Nutrition, Healthcare
Document type:
Clinical Procedure
Organization / institution:
Canberra Health Services
Author:
Not specified
Target audience:
Clinical staff
Period of validity:
Ongoing
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / City:
Canberra
Topic:
Paediatric Parenteral Nutrition
Document Type:
Guideline
Organization / Institution:
Canberra Health Services
Author:
SCHN Multidisciplinary Team
Target Audience:
Clinicians, Parents/Carers
Effective Period:
Not specified
Approval Date:
13/06/2023
Amendment Date:
13/06/2023
Year:
2016
Region / City:
STEGH
Topic:
Parenteral Nutrition
Document Type:
Clinical Practice Guideline (CPG)
Organization:
Clinical Educators, Registered Dietitians
Author:
Chief Nursing Executive
Target Audience:
Healthcare professionals (nurses, dietitians, physicians)
Effective Date:
January 2016
Revision Date:
June 2021
Year:
2026
Region / City:
Not specified
Topic:
Cancer, Parenteral nutrition, Fatigue, Physical function
Document type:
Case report
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Healthcare professionals, researchers
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2016/17
Region / city:
Wandsworth
Topic:
Healthcare Services, Clinical IT, Medical Guidelines
Document Type:
Guidelines
Target Audience:
Healthcare professionals, medical staff
Effective Period:
2016-2017
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / city:
Australia
Subject:
Pharmaceutical compounding guidelines
Document Type:
Guideline
Organization / Institution:
Pharmacy Board of Australia
Author:
Pharmacy Board of Australia
Target Audience:
Registered pharmacists, education providers, employers
Period of validity:
Indefinite
Approval Date:
Not specified
Date of amendments:
Not specified
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Year:
2025
Region / City:
Washington
Topic:
Pharmacy, Pharmaceutical Regulations
Document Type:
Self-Inspection Worksheet
Organization / Institution:
WA Pharmacy Quality Assurance Commission
Author:
Not specified
Target Audience:
Pharmacy Managers, Pharmacists
Effective Period:
March 2025
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / city:
California
Topic:
Veterinary compounding, legal requirements, inspection, best practices
Document Type:
Regulatory guidelines
Organization:
Veterinary Medical Board (VMB)
Author:
California State Government
Target Audience:
Veterinarians, veterinary facilities
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2006
Region / City:
India
Subject:
Electricity theft and compounding procedure
Document Type:
Commercial Circular
Issuing Authority:
Chief Engineer (Commercial)
References:
Commercial Circular Nos. 17 (18.10.2005), 31 (09.02.2006), 32 (28.03.2006)
Legal Basis:
Section 152, Electricity Act 2003
Target Audience:
Electricity supply officers and authorized personnel
Procedure Included:
Guidelines for reconnection and compounding charges
Action Required:
Payment verification and record entry in consumer ledger
Distribution:
As per mailing list
Year:
2026
Region / City:
Manchester, United Kingdom
Subject:
Graphene, Compounding, Nanomaterials
Document Type:
Press Release
Organization:
HydroGraph Clean Power Inc.
Author:
Matt Kreps, Vice President of Investor Relations
Target Audience:
Industry professionals, investors
Effective Period:
February 10, 2026
Approval Date:
February 10, 2026
Date of Changes:
None
Note:
Description
Year:
2016
Region / City:
Suffolk County, Massachusetts
Theme:
Pharmacy Regulations
Document Type:
Agreement
Organization / Institution:
Massachusetts Board of Registration in Pharmacy
Author:
Massachusetts Board of Registration in Pharmacy
Target Audience:
Licensed Pharmacists, Pharmacy Organizations, Regulatory Authorities
Period of Effect:
1 year (from the Effective Date)
Approval Date:
6/26/2019
Date of Changes:
7/8/2019
Year:
2026
Region / City:
United States
Subject:
Pharmacy compounding and regulatory compliance
Document Type:
Inspection checklist / Compliance report
Regulatory Authority:
FDA, DEA, State Pharmacy Boards
Pharmacy Name:
Not specified
Store Number:
Not specified
Address:
Not specified
Manager of Record:
Not specified
Inspection Dates:
Not specified
Compounding Risk Level:
Simple / Moderate / Complex
Compounded Products:
Non-sterile medications, dietary/nutritional supplements
Target Audience:
Pharmacy staff, regulatory inspectors
Operating Hours:
M–F, Sat, Sun
Licenses:
Pharmacy license, MOR license
Storage Monitoring:
Temperature and conditions monitoring for drugs and components
Year:
2023
Country:
Mozambique
Region:
Africa Region
Theme:
Poverty, inequality, labor market, and economic vulnerability
Document Type:
Poverty assessment report
Institution:
World Bank
Department:
Poverty and Equity Global Practice
Subject Areas:
Economic growth, inequality, labor markets, fiscal policy, climate shocks, and social welfare
Geographic Scope:
National analysis with provincial comparisons
Time Period Covered:
Approximately 1996–2023 with detailed analysis for 2014/15–2019/20 and 2015–2020
Key Topics:
COVID-19 impacts on poverty, multidimensional deprivation, inequality trends, labor market conditions, fiscal incidence, climate and weather shocks
Data Sources:
Household surveys, national accounts, fiscal incidence analysis, and poverty measurement frameworks
Analytical Components:
Statistical analysis, poverty trends, inequality measurement, labor market profiling, and policy considerations
Annexes:
Poverty measurement, inequality analysis, labor market decomposition, fiscal incidence analysis, and climate shock modelling
Year:
2024
Type of document:
Policies and procedures manual
Subject:
Non-sterile pharmacy compounding
Organization:
Alberta College of Pharmacy (ACP)
Responsible individuals:
Compounding Supervisor and other staff involved
Last updated:
Month/Day/Year
Last reviewed:
Month/Day/Year
References updated:
February 5, 2024
Target audience:
Pharmacy personnel
Sections included:
General operations, personnel and facilities, compounded preparations, quality assurance, additional resources
Year:
2023
Location:
Udon Thani, Thailand
Topic:
Healthcare Economics
Document Type:
Cost Analysis Report
Institution:
Udon Thani Cancer Hospital
Author:
Not specified
Target Audience:
Hospital Administrators, Health Economists
Data Collection Period:
October 2022 – September 2023
Costing Method:
Standard (conventional) costing
Cost Centers:
Absorbing and Transient
Cost Components:
Labor, Material, Capital, Indirect Costs
Exclusions:
Chemotherapy drug costs